Fate Therapeutics (FATE)
(Delayed Data from NSDQ)
$4.14 USD
-0.10 (-2.36%)
Updated May 16, 2024 04:00 PM ET
After-Market: $4.14 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Brokerage Reports
Fate Therapeutics, Inc. [FATE]
Reports for Purchase
Showing records 421 - 426 ( 426 total )
Company: Fate Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Fate Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Fate Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Fate Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Fate Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Q3:13 EPS: New Formulation Ready for the Clinic in H1:14, Two Wnt7a Leads Picked for IND-Enabling Studies, Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Fate Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Initiating Coverage With an OUTPERFORM Rating and $14 Price Target; Fated to Create Better Stem Cells
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D